Published in Cardiovascular Device Liability Week, December 13th, 2009
"A total of 306 patients at least 60 yr old were randomized to receive dexmedetomidine (0.1-0.7 mu g. kg(-1) h(-1)) or morphine (10-70 mu g. kg(-1). h(-1)) with open-label propofol titrated to a target Motor Activity Assessment Scale of 2-4. was the prevalence of delirium measured daily...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Device Liability Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.